At the news
? NEUTRALIMPACT 2/10 144 filed Jul 2, 2026 at 16:00 ET
CEO Matthew Kapusta filed a Form 144 to sell 21,082 ordinary shares valued at ~$952K. The notice indicates the sale is part of an established 10b5-1 trading plan adopted in October 2025 and cites a stock option exercise. This is a pre-planned sale with no new discretionary insider signal, and the overall insider activity (including recent prior sells) is consistent with plan-driven liquidity.
- Reporting person: Matthew C. Kapusta, CEO and Managing Director of uniQure N.V.
- Proposed sale: 21,082 ordinary shares via Citigroup Global Markets
- Estimated value: ~$951,932 (approx. 0.034% of market cap at $2.8B)
- Shares to be sold after filing: 21,082, with balance held of 63,067,485
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access